Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03654651 · ClinicalTrials.gov registry record · Phase 2
Peanuts and Glycemic Control
A Phase 2 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT03654651 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 51 participants.
The verdict
NCT03654651, a Phase 2 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
A two-period randomized crossover study will be conducted to determine the effect of peanuts on glycemic control, and elucidate the role of the microbiome in glucose regulation, in individuals with impaired fasting glucose.
Interventions
- DRUG Peanut
- DRUG High carbohydrate snack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-12-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03654651
The ClinicalTrials.gov registry entry for NCT03654651 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peanut is the first listed.
NCT03654651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03654651 about?
NCT03654651 is a clinical study titled "Peanuts and Glycemic Control". A two-period randomized crossover study will be conducted to determine the effect of peanuts on glycemic control, and elucidate the role of the microbiome in glucose regulation, in individuals with impaired fasting glucose.
What is the current status of trial NCT03654651?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2018-10-01. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT03654651?
The interventions under investigation include: Peanut (DRUG), High carbohydrate snack (DRUG).
Who is sponsoring clinical trial NCT03654651?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.